Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Update: Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension [Phase 2, Phase 3]
A Phase 2/3 clinical trial update for QLS-111-FDC in open-angle glaucoma and ocular hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Update: Long-term Safety and Efficacy Extension Trial of Bimatoprost SR [Phase 3]
Phase 3 long-term safety and efficacy extension study of Bimatoprost SR has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Update: Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update for QLS-111-FDC in open-angle glaucoma and ocular hypertension; status is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma [NA]
Clinical trial update for the Cilioscleral Interposition Device SV22 in primary open-angle glaucoma and angle-closure glaucoma; the study st…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Electrical Stimulation for the Treatment of Glaucoma [NA]
Stanford University is conducting a clinical trial to evaluate electrical stimulation as a treatment for glaucoma, including open-angle glau…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction [Phase 3]
Phase 3 trial update reporting completion of evaluation for reformulated PG324 ophthalmic solution aimed at reducing intraocular pressure. T…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: DSLT for Reducing Medication in Glaucoma
Clinical trial update indicates a study evaluating DSLT to reduce glaucoma medications is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma
This clinical trial update reports on a study evaluating bio-reinforced canaloplasty for open-angle glaucoma, with enrollment currently by i…
-
FDA approval · 2026-04-09FDA Approved: COSOPT PF — Supplemental Application (Thea Pharma Inc.)
The FDA approved a supplemental application for COSOPT PF (dorzolamide hydrochloride and timolol maleate) by Thea Pharma Inc., marking an ad…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension [Phase 2, Phase 3]
Status update for a Phase 2/3 trial of QLS-111-FDC in open-angle glaucoma and ocular hypertension; recruitment is currently ongoing.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study
This clinical trial update reports five-year postoperative outcomes for patients who completed the CREST glaucoma study.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 clinical trial comparing BL1107 eye drops to timolol for primary open-angle glaucoma or ocular hypertension, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Trial of Hydrus Microstent Versus Goniotomy [NA]
A clinical trial comparing the Hydrus Microstent to goniotomy for open-angle glaucoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.
An extension trial for patients with open-angle glaucoma who participated in the DF6-CL-20-01 protocol has been terminated.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Preserflo MicroShunt Versus Trabeculectomy [NA]
A clinical trial comparing the PreserFlo MicroShunt to trabeculectomy for open-angle glaucoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial studying GVB-2001 gene therapy delivered via intracameral injection for primary open-angle glaucoma is currently …
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Combined Non-Invasive Brain and Visual Stimulation for Vision Improvement [NA]
A non-recruiting clinical trial sponsored by The Hong Kong Polytechnic University is exploring combined non-invasive brain and visual stimul…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients [Phase 4]
This entry describes a Phase 4 trial comparing Rocklatan to latanoprost in open-angle glaucoma and ocular hypertension, which is currently r…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
This ClinicalTrials.gov entry describes a Phase 1/2 study of AGN-193408 SR for open-angle glaucoma and ocular hypertension, currently recrui…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma [Phase 3]
Phase 3 study evaluating adverse events and effectiveness of Gel Stent (XEN63) implantation using ab interno and ab externo approaches in ad…
-
FDA approval · 2026-03-18FDA Approved: APRACLONIDINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for apraclonidine from Sandoz Inc.
-
FDA approval · 2026-03-18FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)
FDA approved a supplemental application for IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution) from Harrow Eye, LLC, indicating a…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Personalized Mobile Reminders for Medication Adherence and Intraocular Pressure Control in Primary Open-Angle Glaucoma [NA]
A clinical trial evaluating personalized mobile reminders to improve medication adherence and intraocular pressure control in primary open-a…
-
FDA approval · 2026-03-17FDA Approved: COMBIGAN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for COMBIGAN (brimonidine tartrate and timolol maleate) submitted by Allergan, Inc.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options
This clinical trial compares patient-reported quality of life after glaucoma surgery across different surgical options and is currently recr…